The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 05, 2016

Filed:

Jul. 11, 2014
Applicant:

Rigshospitalet, Copenhagen, DK;

Inventors:

Pär Johansson, Dösjebro, SE;

Sisse Rye Ostrowski, Gentofte, DK;

Assignee:

Rigshospitalet, Kobenhavn Ø, DK;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/36 (2006.01); A61K 31/34 (2006.01); A61K 39/395 (2006.01); A61K 31/557 (2006.01); A61K 31/727 (2006.01); A61K 45/06 (2006.01); A61K 31/5585 (2006.01);
U.S. Cl.
CPC ...
A61K 39/3955 (2013.01); A61K 31/557 (2013.01); A61K 31/5585 (2013.01); A61K 31/727 (2013.01); A61K 45/06 (2013.01);
Abstract

The present invention relates to compounds for treatment that protects the endothelium, prevents pathologic thrombus formation in the microcirculation and preserves platelet number and function and thus may be related to minimizing or preventing development of organ failure, including multiple organ failure (MOF), and, hence, death in critically ill patients by administration of agent(s) limiting the platelets ability to aggregate and form clots and/or by agents modulating/preserving endothelial integrity and/or by agent(s) increasing the rate of thrombus lysis, and Another aspect of the invention related to by a cell-based whole blood viscoelastical haemostatic assay identifying critically ill patients at increased risk of development of organ failure, including multiple organ failure (MOF) and death.


Find Patent Forward Citations

Loading…